Patrick Soon Shiong, MD: Justice & American Values During the Coronavirus Pandemic

Segment Description: Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.

Part 1: SARS-CoV-2 Vaccine: Does Nucleocapsid DNA Lead to Lasting Protection?

Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, explains why the firm's SARS-CoV-2 vaccine candidate uses Nucleocapsid DNA alongside Spike DNA.

Part 2: Goals of Operation Warp Speed

Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.

Related Coverage: Racial Disparities in Coronavirus Incidence, Knowledge, and Exposure

A recent US survey showed African American men were more likely to know someone infected by COVID-19, had a greater knowledge disparity of how the virus spread, and were more likely to be exposed to the virus.

Marcella Alsan, MD, MPH, PhD, associate professor of medicine, Stanford University, led a team of investigators who developed the survey and analyzed the results. The survey’s findings were reported in JAMA.

Read the full story.

Related Coverage: Inadequate Insurance Coverage Drives COVID-19 Racial & Economic Disparities

While calls for racial justice have reached a groundswell in recent weeks, it is clear from the COVID-19 pandemic and response that many health care inequities tied to both race and cross-racial economic factors are a long way from resolution.

According to Johns Hopkins University as of June 12, roughly 2,029,037 individuals have been confirmed to have contracted SARS-CoV-2. Even outside the most concerning pools of individuals at high-risk for severe infection, the outbreak carries risks for substantial financial consequences for any American hospitalized or kept out of work.

Read the full story.